Syra Health

Syra Health ROE

The Return on Equity (ROE) of Syra Health (SYRA) as of Oct 21, 2026 is -42.72 %. In the previous year, Return on Equity (ROE) was -130.59 % — a change of -67.29% (higher).

ROE

-42.72 %

YoY

-67.29%

Last updated:

In 2025, Syra Health's return on equity (ROE) was -42.72 %, a -67.29% increase from the -130.59 % ROE in the previous year.

The Syra Health ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2020
102.40 USD
Jan 1, 2021
45.89 USD
Jan 1, 2022
-298.29 USD
Jan 1, 2023
-73.22 USD
Jan 1, 2024
-130.59 USD
Jan 1, 2025
-42.72 USD
The Syra Health ROE history
YEARROEYoY
-42.72 %-67.29%
-130.59 %+78.37%
-73.22 %-75.45%
-298.29 %-749.97%
45.89 %-55.18%
102.40 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Syra Health Stock analysis

What does Syra Health do? Syra Health Corp generates revenue through comprehensive end-to-end healthcare services including health education, population health management, behavioral and mental health, healthcare workforce solutions, and digital health. The company provides medical communications, patient education, and healthcare training under health education services. Population health management includes analytics as a service, epidemiology, and health equity analytics. Digital health solutions encompass digital transformation, cloud and security, artificial intelligence, patient engagement, and health applications. Workforce staffing solutions target mental health hospitals, government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers. The firm's services are sold to mental health hospitals, government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers. These segments represent the primary customer base for Syra Health Corp's offerings. The company's health education services include medical communications, patient education, and healthcare training, which are tailored to meet the needs of healthcare providers and organizations. Population health management services focus on analytics-driven solutions for health equity and epidemiology. Digital health solutions are delivered through artificial intelligence, patient engagement platforms, and health applications, targeting healthcare organizations seeking to enhance digital capabilities. Workforce staffing solutions support mental health hospitals and other healthcare providers with specialized staffing needs. The company's portfolio is structured to address key healthcare challenges faced by its target segments, including population health analytics and digital transformation requirements. Syra Health is one of the most popular companies on Eulerpool.

ROE Details

Decoding Syra Health's Return on Equity (ROE)

Syra Health's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Syra Health's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Syra Health's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Syra Health’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Syra Health stock

Return on Equity (ROE) of Syra Health is -42.72 % in 2025.

Return on Equity (ROE) of Syra Health changed from -130.59 % to -42.72 %, representing a -67.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Syra Health since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Syra Health with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Syra Health

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Syra Health